Due to a lack of representative utility data for Taiwanese patients with T2D, a cost-utility analysis was not conducted
Prescription product
What the Evidence Shows and What It Does Not MedicalDaily Evidence Check Study type: Phase 2b randomized clinical trial Participants: 272 adults with type 2 diabetes, average age 50.8, from 37 sites in China Published in: Annals of Internal Medicine , June 30, 2026 (DOI: 10.7326/ANNALS-25-04623) What it found: Biweekly bofanglutide produced HbA1c reductions and weight loss comparable to weekly semaglutide in Chinese patients with type 2 diabetes What it did not prove: The trial was not conducted in U.S
Methionine, carnitine, and choline
Consistency is key to getting the most benefits from these supplements, especially when it comes to long-term gut health, maintaining muscle mass, and supporting hair density and skin elasticity.* Why stick packs
Most patients notice body composition improvements within four to eight weeks of consistent use